Target Therapie Archive

Languages

info@iozk.de

The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma.2019-07-31 - 12:08
Response of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery.2019-07-31 - 12:07
Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).2019-07-31 - 11:54

The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma.2019-07-31 - 12:08
Response of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery.2019-07-31 - 12:07
Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).2019-07-31 - 11:54
A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.2019-07-31 - 11:52
Can Dendritic Cell Vaccination Prevent Leukemia Relapse?2019-06-22 - 00:00
Dendritic cell/cytokine-induced killer cell-based immunotherapy in lung cancer: What we know and future landscape2019-06-21 - 00:00

IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland

T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de

The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma.
Response of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery.
Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).